Intermediate-dose cytosine arabinoside and amsacrine : an effective regimen with low toxicity in refractory acute nonlymphocytic leukemiaDEKKER, A. W; NIEUWENHUIS, K; VERDONCK, L. F et al.Cancer. 1990, Vol 65, Num 9, pp 1891-1894, issn 0008-543X, 4 p.Article

Ether lipids are effective cytotoxic drugs against multidrug-resistant acute leukemia cells and can act by the induction of apoptosisVERDONCK, L. F; VAN HEUGTEN, H. G.Leukemia research. 1997, Vol 21, Num 1, pp 37-43, issn 0145-2126Article

Is cytomegalovirus infection a major cause of T cell alterations after (autologous) bone-marrow transplantation?VERDONCK, L. F; DE GAST, G. C.Lancet (British edition). 1984, Num 8383, pp 932-935, issn 0140-6736Article

Intensive treatment for multiple myeloma : Where do we stand?LOKHORST, H. M; SONNEVELD, P; VERDONCK, L. F et al.British journal of haematology. 1999, Vol 106, Num 1, pp 18-27, issn 0007-1048Article

Successful treatment with chemotherapy and subsequent allogeneic bone marrow transplantation for myeloid blastic crisis of chronic myelogenous leukemia following advanced Hodgkin's diseasePUNT, C. J. A; ROZENBERG-ARSKA, M; VERDONCK, L. F et al.Cancer. 1987, Vol 60, Num 5, pp 934-935, issn 0008-543XArticle

Delay in platelet recovery after bone marrow transplantation: impact of cytomegalovirus infectionVERDONCK, L. F; VAN HEUGTEN, H; DE GAST, G. C et al.Blood. 1985, Vol 66, Num 4, pp 921-925, issn 0006-4971Article

Infection prevention in autologous bone marrow transplantation and the role of protective isolationDEKKER, A. W; VERDONCK, L. F; ROZENBERG-ARSKA, M et al.Bone marrow transplantation (Basingstoke). 1994, Vol 14, Num 1, pp 89-93, issn 0268-3369Article

Prevention of bacteremias caused by α-hemolytic streptococci by roxithromycin in patients treated with intensive cytotoxic treatmentDEKKER, A. W; ROZENBERG-ARSKA, M; VERDONCK, L. F et al.Haematology and blood transfusion. 1990, Vol 33, pp 551-554, issn 0171-7111Article

Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasiaLODEWYCK, T; OUDSHOORN, M; WILLEMZE, R et al.Leukemia. 2011, Vol 25, Num 10, pp 1548-1554, issn 0887-6924, 7 p.Article

The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma : reduced relapse risk in female to male transplantsGAHRTON, G; IACOBELLI, S; KRÖGER, N et al.Bone marrow transplantation (Basingstoke). 2005, Vol 35, Num 6, pp 609-617, issn 0268-3369, 9 p.Article

Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion techniqueMEIJER, E; SLAPER-CORTENBACH, I. C. M; THIJSEN, S. F. T et al.Bone marrow transplantation (Basingstoke). 2002, Vol 29, Num 4, pp 335-339, issn 0268-3369Article

Cost analysis of CHOP (-like) chemotherapy regimens for patients with newly diagnosed aggressive non-Hodgkin's lymphomaVAN AGTHOVEN, M; FABER, L. M; UYL-DE GROOT, C. A et al.European journal of haematology. 2002, Vol 69, Num 4, pp 213-220, issn 0902-4441, 8 p.Article

Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myelomaLOKHORST, H. M; SONNEVELD, P; VETH, G et al.Bone marrow transplantation (Basingstoke). 1999, Vol 23, Num 4, pp 317-322, issn 0268-3369Article

The depletion of T cells from haematopoietic stem cell transplantsSLAPER-CORTENBACH, I. C. M; WIJNGAARDEN-DU BOIS, M. J. G. J; DE VRIES-VAN ROSSEN, A et al.Rheumatology (Oxford. Print). 1999, Vol 38, Num 8, pp 751-754, issn 1462-0324Conference Paper

Allogeneic bone Marrow transplantation for low-grade lymphomaVAN BESIEN, K; SOBOCINSKI, K. A; MCCARTHY, P. L et al.Blood. 1998, Vol 92, Num 5, pp 1832-1836, issn 0006-4971Article

A risk-adapted approach with a short course of ganciclovir to prevent cytomegalovirus (CMV) pneumonia in CMV-seropositive recipients of allogeneic bone marrow transplantsVERDONCK, L. F; DEKKER, A. W; ROZENBERG-ARSKA, M et al.Clinical infectious diseases. 1997, Vol 24, Num 5, pp 901-907, issn 1058-4838Article

Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma : A retrospective case-matched study from the European group for blood and marrow transplantationBJÖRKSTRAND, B; LJUNGMAN, P; GOLDSTONE, A. H et al.Blood. 1996, Vol 88, Num 12, pp 4711-4718, issn 0006-4971Article

Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high-affinity filtersVAN PROOIJEN, H. C; VISSER, J. J; VAN OOSTENDORP, W. R et al.British journal of haematology. 1994, Vol 87, Num 1, pp 144-147, issn 0007-1048Article

Salvage therapy with proMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who failed to respond to first-line CHOPVERDONCK, L. F; DEKKER, A. W; DE GAST, G. C et al.Journal of clinical oncology. 1992, Vol 10, Num 12, pp 1949-1954, issn 0732-183XArticle

Cytomegalovirus infection causes delayed platelet recovery after bone marrow transplantationVERDONCK, L. F; DE GAST, G. C; VAN HEUGTEN, H. G et al.Blood. 1991, Vol 78, Num 3, pp 844-848, issn 0006-4971Article

A fixed low number of T cells in HLA-identical allogeneic bone marrow transplantationVERDONCK, L. F; DE GAST, G. C; VAN HEUGTEN, H. G et al.Blood. 1990, Vol 75, Num 3, pp 776-780, issn 0006-4971Article

The influence of T cell depletion on recovery of T cell proliferation to herpesvirus and Candida after allogeneic bone marrow transplantationDE GAST, G. C; GRATAMA, J. W; VERDONCK, L. F et al.Transplantation. 1989, Vol 48, Num 1, pp 111-115, issn 0041-1337Article

Acute renal failure after allogeneic myeloablative stem cell transplantation : retrospective analysis of incidence, risk factors and survivalKERSTING, S; KOOMANS, H. A; HENE, R. J et al.Bone marrow transplantation (Basingstoke). 2007, Vol 39, Num 6, pp 359-365, issn 0268-3369, 7 p.Article

Single-centre experience with nonmyeloablative allogeneic stem cell transplantation in patients with multiple myeloma: prolonged remissions inducedVAN DORP, S; MEIJER, E; VAN DE DONK, N. W. C. J et al.Netherlands journal of medicine. 2007, Vol 65, Num 5, pp 178-184, issn 0300-2977, 7 p.Article

Differential diagnosis of skin lesions after allogeneic haematopoietic stem cell transplantationCANNINGA-VAN DIJK, M. R; SANDERS, C. J; VERDONCK, L. F et al.Histopathology. 2003, Vol 42, Num 4, pp 313-330, issn 0309-0167, 18 p.Article